FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898416462> ?p ?o ?g. }

• W2898416462 endingPage "1004" @default.
• W2898416462 startingPage "987" @default.
• W2898416462 abstract "Background/Aims: GCNT3 is a member of N-acetylglucosaminyltransferase family involved with mucin biosynthesis. GCNT3 aberrant expression is known to promote the progression of several human cancers. However, its role in tumorigenesis and the progression of non-small cell lung cancer (NSCLC) has not been well-characterized. Our study investigated the functional mechanisms of GCNT3 regulated by microRNAs (miRNAs) in NSCLC. Methods: The differential expression of mRNAs in NSCLC tissues and matched adjacent non-cancerous lung tissues from patients in Xuanwei, Yunnan province, China, was screened via mRNA microarray. The expression of GCNT3 and its correlation with NSCLC progression was measured in 92 paired tumor tissues and adjacent normal tissues. The functions of GCNT3 in NSCLC cells and its underlying mechanisms were measured using siRNA and GCNT3-expression vectors. The miRNA immunoprecipitation (miRIP) method was used to identify the miRNAs targeting GCNT3. The protein were measured using western blot assay, and the mRNAs were measured by quantitative real-time PCR (qRT-PCR) assay. Cell proliferation was measured using Cell Counting Kit-8 (CCK-8) and a colony forming assays; cell migration and invasion assays were performed using 24-well Transwell chambers with 8-μm pores filter, and analyses of the cell cycle and apoptosis were performed via flow cytometric analysis. The dual luciferase reporter assay was performed to confirm whether GCNT3 gene was a direct target of miR-302b-3p. Results: GCNT3 was found to be highly expressed in both NSCLC tissues and cell lines, and higher expression correlated significantly with advanced tumor-node-metastasis (TNM) stage, positive lymph node metastasis, and poor overall survival. Knockdown of GCNT3 inhibited the proliferation, migration and invasion ability of NSCLC cells, while overexpression facilitated these activities. Further mechanistic experiments using miRIP and dual luciferase reporter assays revealed that GCNT3 was a direct target of miR-302b-3p. Low expression of miR-302b-3p was found in NSCLC cells and negatively correlated with GCNT3 levels, while miR-302b-3p overexpression inhibited the proliferation, migration and invasion of NSCLC cells. Co-transfection with miR-302b-3p and the expression vector of GCNT3 abrogated the effects of mir-302b-3p, confirming that miR-302b-3p inhibited NSCLC progression by targeting GCNT3. Western blotting revealed that E-cadherin, N-cadherin, vimentin, p-Erk and cyclin D1 were downstream molecules of miR-302b-3p/GCNT3 pathway. Conclusion: miR-302b-3p/GCNT3 axis regulated cell proliferation, migration, and invasion by activating the Erk signaling pathway and epithelial-mesenchymal transition (EMT), which was identified as a potential therapeutic target for NSCLC." @default.
• W2898416462 created "2018-11-02" @default.
• W2898416462 creator A5009383318 @default.
• W2898416462 creator A5013922859 @default.
• W2898416462 creator A5054013038 @default.
• W2898416462 creator A5072707998 @default.
• W2898416462 creator A5077569128 @default.
• W2898416462 creator A5078395105 @default.
• W2898416462 creator A5082947695 @default.
• W2898416462 creator A5084519953 @default.
• W2898416462 creator A5089166593 @default.
• W2898416462 date "2018-01-01" @default.
• W2898416462 modified "2023-10-06" @default.
• W2898416462 title "Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion" @default.
• W2898416462 cites W1550348245 @default.
• W2898416462 cites W1606879372 @default.
• W2898416462 cites W1869645336 @default.
• W2898416462 cites W1935714551 @default.
• W2898416462 cites W1969375089 @default.
• W2898416462 cites W1973844871 @default.
• W2898416462 cites W2005456467 @default.
• W2898416462 cites W2006797972 @default.
• W2898416462 cites W2011634391 @default.
• W2898416462 cites W2020830322 @default.
• W2898416462 cites W2027263880 @default.
• W2898416462 cites W2035792794 @default.
• W2898416462 cites W2036169252 @default.
• W2898416462 cites W2037823618 @default.
• W2898416462 cites W2039164708 @default.
• W2898416462 cites W2048603557 @default.
• W2898416462 cites W2067988713 @default.
• W2898416462 cites W2068868971 @default.
• W2898416462 cites W2077902938 @default.
• W2898416462 cites W2079251691 @default.
• W2898416462 cites W2080133238 @default.
• W2898416462 cites W2085603446 @default.
• W2898416462 cites W2098953839 @default.
• W2898416462 cites W2113551318 @default.
• W2898416462 cites W2124007301 @default.
• W2898416462 cites W2128331754 @default.
• W2898416462 cites W2131193610 @default.
• W2898416462 cites W2156734818 @default.
• W2898416462 cites W2161587712 @default.
• W2898416462 cites W2165423570 @default.
• W2898416462 cites W2168762200 @default.
• W2898416462 cites W2172255378 @default.
• W2898416462 cites W2220340796 @default.
• W2898416462 cites W2283176086 @default.
• W2898416462 cites W2283965638 @default.
• W2898416462 cites W2329151906 @default.
• W2898416462 cites W2417897392 @default.
• W2898416462 cites W2504132873 @default.
• W2898416462 cites W2520413048 @default.
• W2898416462 cites W2530837075 @default.
• W2898416462 cites W2531068159 @default.
• W2898416462 cites W2563363007 @default.
• W2898416462 cites W2606086568 @default.
• W2898416462 cites W2615399205 @default.
• W2898416462 cites W2622934343 @default.
• W2898416462 cites W2738014443 @default.
• W2898416462 cites W2980907049 @default.
• W2898416462 doi "https://doi.org/10.1159/000494482" @default.
• W2898416462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30355927" @default.
• W2898416462 hasPublicationYear "2018" @default.
• W2898416462 type Work @default.
• W2898416462 sameAs 2898416462 @default.
• W2898416462 citedByCount "29" @default.
• W2898416462 countsByYear W28984164622019 @default.
• W2898416462 countsByYear W28984164622020 @default.
• W2898416462 countsByYear W28984164622021 @default.
• W2898416462 countsByYear W28984164622022 @default.
• W2898416462 countsByYear W28984164622023 @default.
• W2898416462 crossrefType "journal-article" @default.
• W2898416462 hasAuthorship W2898416462A5009383318 @default.
• W2898416462 hasAuthorship W2898416462A5013922859 @default.
• W2898416462 hasAuthorship W2898416462A5054013038 @default.
• W2898416462 hasAuthorship W2898416462A5072707998 @default.
• W2898416462 hasAuthorship W2898416462A5077569128 @default.
• W2898416462 hasAuthorship W2898416462A5078395105 @default.
• W2898416462 hasAuthorship W2898416462A5082947695 @default.
• W2898416462 hasAuthorship W2898416462A5084519953 @default.
• W2898416462 hasAuthorship W2898416462A5089166593 @default.
• W2898416462 hasBestOaLocation W28984164621 @default.
• W2898416462 hasConcept C104317684 @default.
• W2898416462 hasConcept C121608353 @default.
• W2898416462 hasConcept C127561419 @default.
• W2898416462 hasConcept C137738243 @default.
• W2898416462 hasConcept C142724271 @default.
• W2898416462 hasConcept C145059251 @default.
• W2898416462 hasConcept C1491633281 @default.
• W2898416462 hasConcept C153911025 @default.
• W2898416462 hasConcept C2776256026 @default.
• W2898416462 hasConcept C2779013556 @default.
• W2898416462 hasConcept C2779256057 @default.
• W2898416462 hasConcept C29537977 @default.
• W2898416462 hasConcept C502942594 @default.
• W2898416462 hasConcept C54355233 @default.
• W2898416462 hasConcept C553184892 @default.

• next